Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Champions Oncology Inc

CSBR
Current price
5.25 USD +0.07 USD (+1.35%)
Last closed 5.3 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 71 439 760 USD
Yield for 12 month -22.91 %
Week
Month
Year
CSBR
21.11.2021 - 28.11.2021

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Address: One University Plaza, Hackensack, NJ, United States, 07601

Analytics

WallStreet Target Price

8.75 USD

P/E ratio

Dividend Yield

3.26 %

Current Year

+53 870 000 USD

Last Year

+49 109 000 USD

Current Quarter

+12 561 000 USD

Last Quarter

+13 071 000 USD

Current Year

+24 338 000 USD

Last Year

+25 477 000 USD

Current Quarter

+4 877 000 USD

Last Quarter

+5 734 000 USD

Key Figures CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -4 554 000 USD
Operating Margin TTM -20.32 %
PE Ratio
Return On Assets TTM -13.06 %
PEG Ratio
Return On Equity TTM -139.3 %
Wall Street Target Price 8.75 USD
Revenue TTM 52 686 000 USD
Book Value 0.14 USD
Revenue Per Share TTM 3.89 USD
Dividend Share
Quarterly Revenue Growth YOY -8.6 %
Dividend Yield 3.26 %
Gross Profit TTM 24 338 000 USD
Earnings Share -0.56 USD
Diluted Eps TTM -0.56 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -28.6 %
Profit Margin -14.39 %

Dividend Analytics CSBR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 3.26 %
Last Split Factor 1:12
Payout Ratio
Last Split Date 12.08.2015
Dividend Date

Stock Valuation CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 22.8833
Enterprise Value Revenue 1.3913
Price Sales TTM 1.356
Enterprise Value EBITDA -16.0967
Price Book MRQ 36.6907

Financials CSBR

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CSBR

For 52 weeks

3.75 USD 7.32 USD
50 Day MA 5.83 USD
Shares Short Prior Month 72 852
200 Day MA 5.55 USD
Short Ratio 9.57
Shares Short 70 966
Short Percent 1.04 %